Our colleagues at UKONS (UK Oncology Nursing Society) have developed primary care risk assessment tool collaboration with Macmillan that UKONS wish to promote to the wider pharmacy workforce. It’s a really good resource building on the UKONS Risk Assessment Tool which I’m sure you’ll recognise from your
Keep your eye on the news feed for more exciting new about BOPA, collaborating with UKONS.
Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…
Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…
The Spring webinar for Women for Oncology UK is on the 16th May, to sign up click the link below. Women For Oncology UK Spring Webinar Tickets, Wed 14 May…
BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…
The 28th BOPA Annual Conference in 2025 will be held at the ICC Belfast on 3-5 October 2025.
Check out the latest information here: Latest Conference 2025 – BOPA
Everything you need to know
